{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:58:41Z","timestamp":1789520321428,"version":"build-2803163510"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Nonviable cell preparations of<jats:italic>Burkholderia mallei<\/jats:italic>, the causative agent of glanders, were evaluated as potential vaccine candidates in a BALB\/c murine model. Three different<jats:italic>B. mallei<\/jats:italic>cell preparations plus Alhydrogel were evaluated: a heat-killed preparation, an irradiation-inactivated preparation, and a preparation of a capsule-negative mutant strain which had been irradiation inactivated. BALB\/c mice were vaccinated twice with the different<jats:italic>B. mallei<\/jats:italic>preparations, and spleens and sera were collected to determine their cellular and humoral immune responses. All three bacterial cell preparations had essentially the same results in two cellular immune response assays. In a splenocyte proliferation assay, the amount of cell proliferation in response to the homologous immunogen, concanavalin A, or lipopolysaccharide was similar for all the cell preparations. Also, splenocytes from the inoculated mice expressed interleukin 2 (IL-2), gamma interferon, and small amounts of IL-4 and IL-5, and more IL-10 cytokine in the presence of the homologous antigen. When the immunoglobulin subclasses from these mice were examined, they all produced higher levels of IgG1 than IgG2a subclasses. The higher ratio of IgG1 to IgG2a was not due to the amount of the immunogen or the adjuvant (Alhydrogel) used in the BALB\/c mice. The cell preparations did not protect the vaccinated mice from a live challenge (&gt;300 50% lethal doses). Our results suggest that in BALB\/c mice, a mixed T-helper-cell-like response to nonviable<jats:italic>B. mallei<\/jats:italic>is obtained, as demonstrated by a Th1- and Th2-like cytokine response and a Th2-like subclass immunoglobulin response. This may be the reason for the inability of the<jats:italic>B. mallei<\/jats:italic>cells that were examined as candidate vaccines to protect the mice from a live challenge.<\/jats:p>","DOI":"10.1128\/iai.70.5.2319-2325.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:09:01Z","timestamp":1027764541000},"page":"2319-2325","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":38,"title":["Nonviable<i>Burkholderia mallei<\/i>Induces a Mixed Th1- and Th2-Like Cytokine Response in BALB\/c Mice"],"prefix":"10.1128","volume":"70","author":[{"given":"Kei","family":"Amemiya","sequence":"first","affiliation":[{"name":"Pathogenesis and Immunology Branch, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary V.","family":"Bush","sequence":"additional","affiliation":[{"name":"Pathogenesis and Immunology Branch, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DeShazer","sequence":"additional","affiliation":[{"name":"Pathogenesis and Immunology Branch, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Waag","sequence":"additional","affiliation":[{"name":"Pathogenesis and Immunology Branch, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Acha P. N. and B. Szyfres. 1987. Zoonoses and communicable diseases common to man and animals 2nd edition. World Health Organization Washington D.C."},{"key":"e_1_3_2_3_2","first-page":"707","volume":"52","year":"1882","unstructured":"Boerner, P. 1882. A preliminary report on work by the Imperial Health Care Office leading to discovery of the glanders bacillus. Dtsch. Med. Wochenschr.52:707-708. (In German.)","journal-title":"Dtsch. Med. Wochenschr."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-48-1-317"},{"key":"e_1_3_2_5_2","first-page":"1","volume":"49","year":"2000","unstructured":"Centers for Disease Control and Prevention. 2000. Biological and chemical terrorism: strategic plan for preparedness and response. Morb. Mortal. Wkly. Rep.49(RR-4):1-14.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_6_2","first-page":"532","volume":"49","year":"2000","unstructured":"Centers for Disease Control and Prevention. 2000. Laboratory-acquired human glanders--Maryland. Morb. Mortal. Wkly. Rep.49:532-535.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00183-1"},{"key":"e_1_3_2_8_2","first-page":"1518","year":"1986","unstructured":"Davis, C. E. 1986. Glanders (farcy), p. 1518-1521. In A. I. Braude, C. E. Davis, and J. Fierer (ed.), Infectious diseases and medical microbiology. W. B. Saunders Co., Philadelphia, Pa.","journal-title":"Infectious diseases and medical microbiology"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.01139.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.2000.0430"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.37-6-626"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00011-O"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-26-1-93"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.4049\/jimmunol.159.5.2409","volume":"159","year":"1997","unstructured":"Jankovic, D., P. Caspar, M. Zweig, M. G. Moll, S. D. Showalter, F. R. Vogel, and A. Sher. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol.159:2409-2417.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70039-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.532"},{"key":"e_1_3_2_17_2","first-page":"21","volume":"4","year":"1999","unstructured":"Manzeniuk, I. N., Y. A. Galina, V. V. Dorokhin, I. Y. Kalchov, V. N. Borzenkov, and E. A. Svetoch. 1999. Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of malleus and melioidosis. Heterologous vaccines. Antibiot. Khimioter.4:21-26. (In Russian.)","journal-title":"Antibiot. Khimioter."},{"key":"e_1_3_2_18_2","unstructured":"National Institutes of Health. 2000. Public Health Service policy on humane care and use of laboratory animals. Office of Laboratory Animal Welfare National Institutes of Health Bethesda Md."},{"key":"e_1_3_2_19_2","unstructured":"National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.1.34-44.2001"},{"key":"e_1_3_2_21_2","unstructured":"Sell S. I. Berkower and E. E. Max. 1996. Immunology immunopathology and immunity 5th ed. Appleton and Lange Stamford Conn."},{"key":"e_1_3_2_22_2","first-page":"184","year":"1964","unstructured":"Van der Schaaf, A. 1964. Malleus, p. 184-193. In J. Van der Hoeden (ed.), Zoonoses. Elsevier Publishing Co., New York, N.Y.","journal-title":"Zoonoses"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1992.tb02129.x"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.5.2319-2325.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.5.2319-2325.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T16:00:58Z","timestamp":1682265658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.5.2319-2325.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1128\/IAI.70.5.2319-2325.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.5.2319-2325.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]},"assertion":[{"value":"2001-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-01-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}